Cadherin-catenin complex dissociation in lobular neoplasia of the breast

Breast Cancer Research and Treatment

Volumn 132, Issue 2, 2012, Pages 641-652

  Morrogh, Mary ^a   Andrade, Victor P ^a   Giri, Dilip ^a   Sakr, Rita A ^a   Paik, Wooyul ^a   Qin, Li Xuan ^a   Arroyo, Crispinita D ^a   Brogi, Edi ^a   Morrow, Monica ^a   King, Tari A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Catenin; Dissociation; E cadherin; Gene expression; Lobular carcinoma

Indexed keywords

ALPHA CATENIN; BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FORMALDEHYDE; NERVE CELL ADHESION MOLECULE; PARAFFIN; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; DOWN REGULATION; FROZEN SECTION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LASER CAPTURE MICRODISSECTION; LOBULAR CARCINOMA IN SITU; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ALPHA CATENIN; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, COMPLEX AND MIXED; NEW YORK CITY; NUCLEAR PROTEINS; PHOSPHORYLATION; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN BINDING; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TWIST TRANSCRIPTION FACTOR;

EID: 84859100116     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1860-0     Document Type: Article

References (41)

1. Hwang ES, Nyante SJ, Chen YY, Moore D, DeVries S, Korkola JE, Esserman LJ, Waldman FM (2004) Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 100:2562-2572 (Pubitemid 38715760)
2. Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP (2008) Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat 107:331-335 (Pubitemid 351172109)
3. Morandi L, Marucci G, Foschini MP, Cattani MG, Pession A, Riva C, Eusebi V (2006) Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast. Virchows Arch 449:14-23 (Pubitemid 43988361)
4. Mastracci TL, Boulos FI, Andrulis IL, Lam WL (2007) Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer. Breast Cancer Res 9:215
5. Jiang WG, Mansel RE (2000) E-cadherin complex and its abnormalities in human breast cancer. Surg Oncol 9:151-171 (Pubitemid 32722027)
6. Klaus A, Birchmeier W (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8:387-398 (Pubitemid 351589714)
7. Gould Rothberg BE, Bracken MB (2006) E-cadherin immunohistochemical expression as a prognostic factor in infiltrating ductal carcinoma of the breast: a systematic review and meta-analysis. Breast Cancer Res Treat 100:139-148 (Pubitemid 44631915)
8. Nollet F, Berx G, van Roy F (1999) The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun 2:77-85 (Pubitemid 129532310)
9. Baranwal S, Alahari SK (2009) Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 384:6-11
10. Yang SZ, Kohno N, Yokoyama A, Kondo K, Hamada H, Hiwada K (2001) Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines. Int J Oncol 18:541-548
11. Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR (2004) E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 23:1739-1748 (Pubitemid 38649637)
12. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F (1995) E-cadherin is atumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107-6115 (Pubitemid 26007298)
13. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C (1996) E-cadherin isinactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919-1925 (Pubitemid 26397451)
14. Masciari S, Larsson N, Senz J et al (2007) Germline E-cadherin mutations infamilial lobular breast cancer. J Med Genet 44:726-731 (Pubitemid 350155461)
15. Rahman N, Stone JG, Coleman G, Gusterson B, Seal S, Marossy A, Lakhani SR, Ward A, Nash A, McKinna A, A'Hern R, Stratton MR, Houlston RS (2000) Lobular carcinoma insitu of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer 82:568-570 (Pubitemid 30085192)
16. Rieger-Christ KM, Pezza JA, Dugan JM, Braasch JW, Hughes KS, Summerhayes IC (2001) Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol Pathol 54:91-97 (Pubitemid 32270001)
17. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA (2004) Twist, amaster regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939 (Pubitemid 38798858)
18. Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, Reich R, Davidson B (2005) Snail, Slug, and Smadinteracting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103:1631-1643 (Pubitemid 40490024)
19. Come C, Magnino F, Bibeau F, De Santa PB, Becker KF, Theillet C, Savagner P (2006) Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res 12:5395-5402 (Pubitemid 44497253)
20. Morrogh M, Olvera N, Bogomolniy F, Borgen PI, King TA (2007) Tissue preparation for laser capture microdissection and RNA extraction from fresh frozen breast tissue. Biotechniques 43:41-42
21. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:3
22. Wolff AC, Hammond ME, Schwartz JN et al (2007) American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18-43 (Pubitemid 46174133)
23. Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO (2007) High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 31:417-426 (Pubitemid 46673116)
24. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR (2005) Molecular evolution of breast cancer. J Pathol 205:248-254
25. Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO (2008) Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 32:513-523 (Pubitemid 351458293)
26. Wagner PL, Kitabayashi N, Chen YT, Shin SJ (2009) Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases. Am J Clin Pathol 132:871-876
27. Cleton-Jansen AM (2002) E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res 4:5-8
28. Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart IR (2001) Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 92:404-408 (Pubitemid 32249718)
29. Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de Water B, Cornelisse CJ, Cleton-Jansen AM (2006) E-cadherin transcriptional downregulation bypromoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 94:661-671 (Pubitemid 43361897)
30. Zou D, Yoon HS, Perez D, Weeks RJ, Guilford P, Humar B (2009) Epigenetic silencing innon-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia. J Pathol 218:265-272
31. Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR (2006) CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 6:48
32. Vesuna F, van Diest P, Chen JH, Raman V (2008) Twist is atranscriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 367:235-241
33. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, Mehra R, Laxman B, Cao X, Kleer CG, Varambally S, Chinnaiyan AM (2008) Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27:7274-7284
34. Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman JG, Gamallo C, Esteller M, Palacios J (2003) Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 106:208-215 (Pubitemid 36835173)
35. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, Nieto MA (2002) Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21:3241-3246
36. Da Silva L, Parry S, Reid L, Keith P, Waddell N, Kossai M, Clarke C, Lakhani SR, Simpson PT (2008) Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 32:773-783
37. De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183:404-411 (Pubitemid 27509246)
38. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ (2001) Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115:85-98 (Pubitemid 33695094)
39. Nurismah MI, Noriah O, Suryati MY, Sharifah NA (2008) E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer. Asian Pac J Cancer Prev 9:699-702
40. Hashizume R, Koizumi H, Ihara A, Ohta T, Uchikoshi T (1996) Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathology 29:139-146 (Pubitemid 26264438)
41. Goyal A, Martin TA, Mansel RE, Jiang WG (2008) Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome. World J Surg Oncol 6:56